NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Giesen, Eva, Jilaveanu, Lucia B., Parisi, Fabio, Kluger, Yuval, Camp, Robert L., Kluger, Harriet M.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2014
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170640/
https://ncbi.nlm.nih.gov/pubmed/24970819
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars